XRCC3 Antibody, Clone: [10F1/6], Mouse, Monoclonal

Artikelnummer: NSJ-V8167-100UG
Artikelname: XRCC3 Antibody, Clone: [10F1/6], Mouse, Monoclonal
Artikelnummer: NSJ-V8167-100UG
Hersteller Artikelnummer: V8167-100UG
Alternativnummer: NSJ-V8167-100UG
Hersteller: NSJ Bioreagents
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC-P, WB
Spezies Reaktivität: Human
Immunogen: A recombinant full-length human XRCC3 protein was used as the immunogen for this XRCC3 antibody.
The x-ray repair cross-complementing (XRCC) proteins are responsible for efficiently repairing and maintaining genetic stability following DNA base damage. These genes share sequence similarity with the yeast DNA repair protein Rad51. XRCC1 is a protein that facilitates the DNA base excision repair pathway by interacting with DNA ligase III and DNA polymerase to repair DNA single-strand breaks. XRCC2 and XRCC3 are both involved in maintaining chromosome stability during cell division. XRCC2 is required for efficient repair of DNA double-strand breaks by homologous recombination between sister chromatids, and XRCC3 interacts directly with Rad51 to cooperate with Rad51 during recombinational repair. XRCC4 is an accessory factor of DNA Ligase IV that preferentially binds DNA with nicks or broken ends. XRCC4 binds to DNA Ligase IV and enhances its joining activity, and it is also involved in V(D)J recombination. Any defect in one of the known components of the DNA repair/V(D)J recombination machinery (Ku-70, Ku-80, DNA-PKCS, XRCC4 and DNA Ligase IV) leads to abortion of the V(D)J rearrangement process and early block in both T and B cell maturation.
Klonalität: Monoclonal
Klon-Bezeichnung: [10F1/6]
UniProt: O43542
Reinheit: Protein G affinity chromatography
Formulierung: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: Western blot: 1-2ug/ml,Immunohistochemistry (FFPE): 1-2ug/ml
Anwendungsbeschreibung: Optimal dilution of the XRCC3 antibody should be determined by the researcher.